Table 1 Correlation between the HAUS5 expression and pathological features of LIHC in OS and PFS.

From: Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer

Clinicopathological characteristics

Overall survival (n = 364)

Progression-free survival (n = 370)

N

Hazard ratio

p

N

Hazard ratio

p

Gender

 Female

118

2.38(1.29–4.39)

0.0043

120

1.66(0.97–2.85)

0.061

 Male

246

1.68(1.07–2.63)

0.023

246

1.69(1.18–2.43)

0.0041

TNM stage

 I + II

253

2.63(1.61–4.30)

6.20E-05

254

1.64(1.10–2.45)

0.014

 III + IV

87

0.78(0.43–1.42)

0.420

88

1.61(0.85–3.06)

0.140

Grade

 1

55

0.65(0.24–1.72)

0.380

55

1.89(0.86–4.18)

0.110

 2

174

2.13(1.24–3.68)

0.0053

175

2.02(1.22–3.32)

0.0051

 3

118

1.66(0.88–3.12)

0.110

119

1.92(0.98–3.79)

0.054

 4

12

  

12

  

Alcohol consumption

 Yes

115

1.95(0.88–4.33)

0.093

115

2.14(1.17–3.93)

0.012

 No

202

2.03(1.27–3.26)

0.0028

204

1.51(0.98–2.34)

0.061

Hepatitis virus

 Yes

150

2.55(1.32–4.95)

0.0041

152

0.85(0.50–1.43)

0.530

 No

167

1.73(1.07–2.80)

0.023

167

2.75(1.68–4.49)

2.70E-05

Vascular invasion

 None

203

1.73(1.00–3.01)

0.049

204

1.33(0.84–2.10)

0.220

 Micro

90

2.07(0.96–4.45)

0.058

91

1.72(0.96–3.08)

0.063

 Macro

16

     
  1. Bold values indicate p < 0.05.